Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
See Latest ArticlesTreatment of candidemia and invasive candidiasis in the intensive care unit: post hoc analysis of a randomized, controlled trial comparing micafungin and liposomal amphotericin B
Critical Care, 10/20/09
Dupont BF et al. – Overall, ICU subjects had lower treatment success rates than non–ICU subjects for both liposomal amphotericin B and micafungin. Multivariate regression after controlling for potential confounding factors suggested APACHE II score remained a potential explanatory factor associated with treatment success, mortality at day 8, and mortality at day 30.
Related Articles
New Approach for Diagnosis of Candidemia Based on Detection of a 65-Kilodalton Antigen
Clinical and Vaccine Immunology, 11/03/09
Relevance Score: 87%
The Value of a Risk Model for Early-onset Candidemia
Critical Care, 11/17/09
Relevance Score: 82%
Candidiasis: New agents for invasive infections
The Clinical Advisor, 10/06/09
Relevance Score: 80%
Today in Fungal Infections...keeping you current
Receive free subspecialty "5-minute updates" via email
IFI = invasive fungal infections. What is that? A misnomer, because a non-invasive fungal infection does not exist
International Journal of Infectious Diseases, 12/10/09
Accumulation of CD11b+ Lung Dendritic Cells in Response to Fungal Infection Results from the CCR2-Mediated Recruitment and Differentiation of Ly-6Chigh Monocytes
Journal of Immunology, 12/10/09
Infections after the use of alemtuzumab in solid organ transplant recipients: a comparative study
Diagnostic Microbiology and Infectious Disease, 12/09/09
Article Search
Sponsor